Location: Champalimaud Centre for the Unknown, Lisbon
Employer: Champalimaud Foundation
Job Type: Full Time
Position: Postdoctoral Positions
Application Starts: 26 Jul. 2021

Fundação D. Anna de Sommer Champalimaud e Dr. Carlos Montez Champalimaud (Champalimaud Foundation), a private, non-profit research institution, is opening a call for a Postdoctoral Researcher for Papanikolaou group.

Eligible candidates must hold a PhD or Doctorate degree and will be offered an employment contract with unknown term, within the scope of the research project entitled “ProCancer-i”; with the reference “952159” – from the call Nº H2020-SC1-FA-DTS-2019-1, funded by the European Union’s Horizon 2020 research and innovation programme.

The contract is to be entered into by and between the Champalimaud Foundation and the selected candidate in accordance with all applicable legislation, including Law-Decree 57/2016, of the 29 of August of 2016 in its current edition and the General Labour Code, as well as the internal rules and regulations of the Champalimaud Foundation, taking into account the conditions set out in the above mentioned Law-Decree for the recruitment of PhD Holders within the scope of research projects funded by public funds
Work Plan

Participate in the development of Deep Learning based models and Radiomics Signatures that will be extracted from mpMRI images from a total number of 17000 patients with prostate cancer, with a focus on statistical analysis concepts including but not limited to feature selection/reduction, ML modelling using survival analysis and other clinical outcomes.

Highlights

European Cancer Imaging Initiative launch event

European Cancer Imaging Initiative launch event

The Commission is organising a hybrid event on 23 January 2023 in Brussels to mark the launch of the Cancer Imaging Initiative, one of the Flagship Initiatives of the Europe’s Beating Cancer Plan. This 2.5-hour event will present the policy background and the Cancer...

ProCAncer-I at the RSNA 2022 in Chicago

ProCAncer-I at the RSNA 2022 in Chicago

Our Scientific Manager, Dr Nickolas Papanikolaou was at the 108th Scientific Assembly and Annual meeting (Chicago 27-30/11/2022). The panel discussion included Dr Mona Flores, Global Head of Medical AI at NVIDIA, and Dr Nikos Papanikolaou, Computational Clinical...

ProCAncer-I is proud to be part of the European Federation for Cancer Images (#EUCAIM) project and the European Cancer Imaging Initiative!
Read more about EUCAIM and the Initiative here 👉 https://bit.ly/3XLMT7s
#euCancerImaging #HorizonEU #EU_HEALTH
#EUCancerPlan @eHealth_EU

📢 Job Opportunity!
The @qtimlab is currently looking for a Postdoctoral Research Fellow in medical image analysis with deep learning.
Read more here 👉 https://www.procancer-i.eu/job-openings
#jobalert #jobopening #ClinicalReasearch #sciencecareers #careers #H2020 #HorizonEU #EU_HEALTH

The #EUCAIM project originates from the work and expertise of the AI for Health Imaging Network (AI4HI), composed of INCISIVE, @chaimeleon_eu, @EuCanImage, @ProCAncer_I and @primage_project. #EUCancerImaging #DigitalEU #EUCancerPlan https://digital-strategy.ec.europa.eu/en/policies/cancer-imaging

Proud to be part of the #EUCAIM project led by @EIBIR_biomed, supporting the #EUCancerImaging Initiative by contributing to an infrastructure of Cancer #images and development & benchmarking of AI tools with #EuroBioImaging Nodes & many other partners.
https://www.eurobioimaging.eu/news/proud-to-be-part-of-the-eucaim-project-/

The launch of #EUCancerImaging Initiative will boost innovative cancer diagnostics and treatment and make screening more precise and accessible.

It shows the potential of digital solutions that can bring hope to cancer patients and their families.

#EUCancerPlan

Load More...

Stay in touch!